Ensuring safe handling of clinical materials for COVID-19 research
Official title: Division of Microbiology and Infectious Diseases (DMID): Clinical Materials Services (CMS), SARS-CoV-2
Funded at Fisher Bioservices, INC. · NIH-11179076 · Data updated 2026-11-12
This study is all about making sure that the materials used in COVID-19 research are handled safely and correctly, which helps improve the quality of clinical trials that could benefit patients like you in the fight against the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fisher Bioservices, INC. NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project start | September 21, 2022 |
| Project end | September 20, 2025 |
| Funding year | 2024 |
| Award (this year) | $500,000 |
| NIH project number | 75N93022C00023-P00003-9999-1 |
| Project ID | NIH-11179076 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals involved in clinical trials for COVID-19 treatments or vaccines.
✕Less likely to help
Patients who are not participating in clinical trials or are not affected by COVID-19 may not receive direct benefits from this research.
What this research studies
This research focuses on maintaining high standards for the handling of clinical materials related to SARS-CoV-2, ensuring that all processes meet Good Manufacturing Practice (cGMP), Good Clinical Practice (GCP), and Good Laboratory Practice (GLP) guidelines. It involves the acquisition, receipt, storage, and shipping of clinical agents and specimens to support clinical trials and research programs aimed at understanding and combating COVID-19. Patients may benefit indirectly through improved research quality and outcomes in clinical trials related to COVID-19.
Why it matters
Potential benefit: If successful, this research could enhance the reliability and safety of clinical trials for COVID-19 treatments and vaccines.
How similar studies have gone: Other research has shown success in improving clinical trial outcomes through adherence to stringent manufacturing and clinical practices.
Where this research is happening
-
Fisher Bioservices, INC.
Rockville, United States Active
Researchers
- Principal investigator: Eyler, Dennis — Fisher Bioservices, INC.
- Study coordinator: Eyler, Dennis
Related research
Other NIH-funded projects on the same topics.
-
How COVID-19 infection and genes may influence memory and dementia risk
This study looks at how getting COVID-19 and a person’s genes together affect the chance of developing memory problems and Alzheimer’s disease later in life.
-
Understanding flu and COVID-19 vaccine responses in people and in the lab
Researchers at Stanford explore how flu and COVID-19 vaccines work in people and in lab tests to improve protection for adults.
-
Oral small molecule inhibitors to block SARS-CoV-2 RNA replication
A Stanford-led project tests a pill that could stop SARS-CoV-2 and related viruses from copying their RNA inside infected cells.
-
Outpatient antiviral cocktails to fight SARS-CoV-2 and future RNA viruses
Researchers at Stanford are developing outpatient antiviral cocktails that could be used easily outside the hospital to treat COVID-19 and future RNA virus infections.
-
Inhibitors for SARS-CoV-2 Proteases to Block Viral Replication
A patient-facing program aims to discover and optimize small molecules that block key SARS-CoV-2 enzymes, potentially reducing viral replication.
-
How different COVID-19 vaccines shape immune responses
This project compares immune reactions after mRNA and adenoviral COVID-19 vaccines to learn how long protection lasts and why some people get breakthrough infections or side effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.